Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07384143

Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders

Led by IRCCS Centro Neurolesi Bonino Pulejo · Updated on 2026-02-03

189

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if sensor-based robotic upper limb rehabilitation can improve cognitive and motor functions in adults with neurological and neurodegenerative disorders, including Parkinson's disease, multiple sclerosis, and stroke. The main questions it aims to answer are: Does sensor-based robotic rehabilitation improve cognitive functions such as attention, memory, and executive functions? Does this rehabilitation lead to better motor recovery and daily functioning compared to conventional therapy? Researchers will compare the experimental group receiving robotic rehabilitation with cognitive tasks to the control group receiving conventional therapy to see if the robotic approach leads to greater improvements in both cognitive and motor outcomes. Participants will: Receive upper limb rehabilitation using robotic devices and virtual reality-based exercises or conventional therapy Complete a series of neuropsychological assessments before and after the intervention to measure cognitive changes Complete motor function tests before and after the intervention to evaluate physical improvements Participate in 25 training sessions, 2-3 times per week, each lasting 60 minutes

CONDITIONS

Official Title

Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-75 years
  • FMA-UL score 0-31: eligible for exoskeletons and robotic devices with high support (Armeo Power, Amadeo, Motore)
  • FMA-UL score 32-47: eligible for end-effectors with medium support (Armeo Spring, Hand Tutor, Diego)
  • FMA-UL score 48-52: eligible for sensor-based devices with low support (Pablo, Diego, Armeo Senso)
  • MoCA score less than or equal to 20
Not Eligible

You will not qualify if you...

  • Severe cognitive disorders
  • Behavioral disorders
  • Sensory disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Centro Neurolesi Bonino-Pulejo

Messina, Maine, Italy, 98124

Actively Recruiting

Loading map...

Research Team

D

Désirée Latella

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here